TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 23583742

Group type: EXPERIMENTAL
Intervention: Dietary depletion of the serotonin precursor tryptophan
Number of subjects: 19

Group type: COMPARATOR
Intervention: Balanced placebo control diet
Number of subjects: 19
Study: 20632010

Group type: EXPERIMENTAL
Intervention: ReSTOR +3 D
Number of subjects: 40

Group type: COMPARATOR
Intervention: ReSTOR +4 D
Number of subjects: 40
Study: 19858379

Group type: COMPARATOR
Intervention: GEM
Number of subjects: 533

Group type: EXPERIMENTAL
Intervention: GEM-CAP
Number of subjects: 533
Study: 17130579

Group type: EXPERIMENTAL
Intervention: Probiotics during the first 6 months of life
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 200
Study: 15550582

Group type: EXPERIMENTAL
Intervention: irinotecan/5‐fluorouracil (5‐FU)/folinic acid (FA)
Number of subjects: 115

Group type: COMPARATOR
Intervention: irinotecan/cisplatin
Number of subjects: 115
Study: 11383193

Group type: EXPERIMENTAL
Intervention: Intermediate-target displays in experiment 1
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Grating contrast and target luminance variations in experiment 2
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Common model explanation for both effects
Number of subjects: 0
Study: 9422404

Group type: EXPERIMENTAL
Intervention: Tacrolimus (TAC) and mycophenolate mofetil (MMF)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Cyclosporine (CsA) and mycophenolate mofetil (MMF)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Conventional CsA (Sandimmune formulation) and azathioprine (AZA)
Number of subjects: 36
Study: 7795000

Group type: EXPERIMENTAL
Intervention: Multi-faceted treatment program for violent spouses
Number of subjects: 0
Study: 2826370

Group type: EXPERIMENTAL
Intervention: Levamisole
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study: 31199319

Group type: EXPERIMENTAL
Intervention: Pacifica app for self-management of stress, anxiety, and depression
Number of subjects: 500
Study: 28389218

Group type: EXPERIMENTAL
Intervention: Walking training (WT), n=22, 15 bouts of 2min of walking interpolated by 2min of upright rest, twice/week for 12 weeks
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control group (CG), n=20, 30min of stretching exercises, twice/week for 12 weeks
Number of subjects: 42
Study: 25591836

Group type: EXPERIMENTAL
Intervention: Educational materials (EMs)
Number of subjects: 2757

Group type: COMPARATOR
Intervention: Standard aromatase inhibitors (AI) alone
Number of subjects: 2757
Study: 23499623

Group type: EXPERIMENTAL
Intervention: Isoproterenol
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Complete RBBB in patients with IVF
Number of subjects: 87

Group type: COMPARATOR
Intervention: Control subjects with RBBB
Number of subjects: 87

Group type: COMPARATOR
Intervention: Patients with IVF without RBBB
Number of subjects: 87
Study: 21238543

Group type: EXPERIMENTAL
Intervention: Continuous upward or downward pitch rotation of the visual field at 30 and 45°/s combined with a 3 degree (30°/s) dorsiflexion tilt of the support surface
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Functional Principal Component Analysis (fPCA) applied to CoM trajectories
Number of subjects: 22
Study: 18307371

Group type: EXPERIMENTAL
Intervention: Meropenem 500 mg, 1000 mg, or 2000 mg every 6 or 8 hours by intravenous infusion
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Meropenem
Number of subjects: 20
Study: 16566555

Group type: EXPERIMENTAL
Intervention: Oxandrolone 10 mg every 12 hours
Number of subjects: 81

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 81
Study: 12658367

Group type: EXPERIMENTAL
Intervention: ApoE4 genotype
Number of subjects: 2

Group type: COMPARATOR
Intervention: Non-ApoE4 genotype
Number of subjects: 2
Study: 11051370

Group type: EXPERIMENTAL
Intervention: 5 mU interferon TIW for 6 months + ribavirin (1000‐1200 mg daily) if HCV‐RNA positive at month 3
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: 3 mU interferon TIW + ribavirin (1000‐1200 mg daily) for 6 months, increased to 5 mU TIW if HCV‐RNA positive at month 3
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: 5 mU interferon TIW + ribavirin (1000‐1200 mg daily) for 6 months
Number of subjects: 140
Study: 8837932

Group type: EXPERIMENTAL
Intervention: Naltrexone
Number of subjects: 99
Study: 1734161

Group type: EXPERIMENTAL
Intervention: Smoking two cigarettes of preferred brand
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Smokers
Number of subjects: 51

Group type: COMPARATOR
Intervention: Nonsmokers
Number of subjects: 51
Study: 3921102

Group type: EXPERIMENTAL
Intervention: Direct referral from optician to ophthalmologist
Number of subjects: 93

Group type: COMPARATOR
Intervention: Referral through general practitioner
Number of subjects: 93
Study: 29985886

Group type: EXPERIMENTAL
Intervention: Intervention phase (multifactorial intervention)
Number of subjects: 18900

Group type: COMPARATOR
Intervention: Control phase (usual care)
Number of subjects: 18900

Group type: COMPARATOR
Intervention: Training phase (intervention training)
Number of subjects: 18900
Study: 26923626

Group type: EXPERIMENTAL
Intervention: Lung ultrasonography (LUS)
Number of subjects: 191

Group type: COMPARATOR
Intervention: Chest radiography (CXR)
Number of subjects: 191

Group type: EXPERIMENTAL
Intervention: Novice physician-sonologists performing LUS
Number of subjects: 191

Group type: EXPERIMENTAL
Intervention: Experienced physician-sonologists performing LUS
Number of subjects: 191

Group type: EXPERIMENTAL
Intervention: Both arms (LUS and CXR)
Number of subjects: 191
Study: 24686046

Group type: EXPERIMENTAL
Intervention: Triple Injection (TI)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Single Injection (SI)
Number of subjects: 96
Study: 22610334

Group type: EXPERIMENTAL
Intervention: Clearfil AP‐X(TM)
Number of subjects: 200

Group type: COMPARATOR
Intervention: 3M Filtek(TM) Z350
Number of subjects: 200
Study: 19890249

Group type: EXPERIMENTAL
Intervention: OATP1B3 polymorphism 334T>G/699G>A in patients receiving MMF with tacrolimus or sirolimus
Number of subjects: 185

Group type: EXPERIMENTAL
Intervention: OATP1B3 334G-699A haplotype
Number of subjects: 185

Group type: EXPERIMENTAL
Intervention: OATP1B3 variant
Number of subjects: 185
Study: 17373169

Group type: EXPERIMENTAL
Intervention: Poly-L-lactic acid (PLLA)
Number of subjects: 65
Study: 16307624

Group type: EXPERIMENTAL
Intervention: Notification of physicians regarding patients' limited health literacy
Number of subjects: 182
Study: 11896506

Group type: EXPERIMENTAL
Intervention: Eprosartan 600 mg plus HCTZ 12.5 mg OD
Number of subjects: 309

Group type: COMPARATOR
Intervention: Eprosartan 600 mg OD
Number of subjects: 309
Study: 10459115

Group type: EXPERIMENTAL
Intervention: Topical 5-fluorouracil (5-FU) applied twice per day for 3 weeks
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Photodynamic therapy (PDT) using topical 5-aminolevulinic acid (5-ALA) and irradiation with a 1200 W metal halogen lamp
Number of subjects: 17

Group type: COMPARATOR
Intervention: Comparison of both treatments
Number of subjects: 17
Study: 8590511

Group type: EXPERIMENTAL
Intervention: Edrophonium 0.125 mg.kg-1
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Edrophonium 0.25 mg.kg-1
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Edrophonium 0.50 mg.kg-1
Number of subjects: 100

Group type: COMPARATOR
Intervention: Normal saline (Group PLAC)
Number of subjects: 100
Study: 2270599

Group type: EXPERIMENTAL
Intervention: Functional therapy with a free way space of greater than or equal to 1.0 mm and cuspid protected guidance
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (22 men)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Functional therapy
Number of subjects: 20
Study: 58196

Group type: EXPERIMENTAL
Intervention: Asian children with vitamin-D deficiency
Number of subjects: 500

Group type: COMPARATOR
Intervention: African, Chinese, and Scottish children
Number of subjects: 500
Study: 31324360

Group type: EXPERIMENTAL
Intervention: Antihypertensive therapy with candesartan
Number of subjects: 1002

Group type: COMPARATOR
Intervention: Antihypertensive therapy without candesartan
Number of subjects: 1002
Study: 28612577

Group type: EXPERIMENTAL
Intervention: Partial nail avulsion
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Total nail avulsion with plate replacement
Number of subjects: 60

Group type: COMPARATOR
Intervention: Total nail avulsion (control group)
Number of subjects: 60
Study: 26032797

Group type: EXPERIMENTAL
Intervention: Short Message Service programme (8 weeks of monitoring/feedback)
Number of subjects: 139

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 139
Study: 23524061

Group type: EXPERIMENTAL
Intervention: Imagery Rescripting (ImRs)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Baseline
Number of subjects: 10

Group type: COMPARATOR
Intervention: Exploration phase (without trauma-focused treatment)
Number of subjects: 10
Study: 21861997

Group type: EXPERIMENTAL
Intervention: Reverse order recall
Number of subjects: 0

Group type: COMPARATOR
Intervention: Free recall
Number of subjects: 0
Study: 19263337

Group type: EXPERIMENTAL
Intervention: 5 mg/kg/d of nonionic iron polymaltose complex + 25 IU vitamin E (as dl‐alpha‐tocopherol acetate) from 2 weeks of age
Number of subjects: 116
Study: 17718920

Group type: EXPERIMENTAL
Intervention: Water-circulating blankets
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Gel-pads
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Intravascular cooling
Number of subjects: 50

Group type: COMPARATOR
Intervention: Conventional cooling
Number of subjects: 50

Group type: COMPARATOR
Intervention: Air-circulating blankets
Number of subjects: 50
Study: 15288371

Group type: EXPERIMENTAL
Intervention: FA- group (without flat affect)
Number of subjects: 24

Group type: COMPARATOR
Intervention: FA+ group (with flat affect)
Number of subjects: 24
Study: 11509799

Group type: EXPERIMENTAL
Intervention: Total ultrafiltration volume >2.5 kg
Number of subjects: 1238

Group type: EXPERIMENTAL
Intervention: Total ultrafiltration volume <=2.5 kg
Number of subjects: 1238

Group type: EXPERIMENTAL
Intervention: Presence of diabetes mellitus, older age, increased number of prescribed antihypertensive medications, lower hematocrit, absence of arrhythmias
Number of subjects: 1238

Group type: EXPERIMENTAL
Intervention: Younger age, increased number of prescribed antihypertensive medications, absence of arrhythmias
Number of subjects: 1238

Group type: COMPARATOR
Intervention: Not available
Number of subjects: 1238
Study: 10211196

Group type: EXPERIMENTAL
Intervention: Video thoracoscopy
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Rigid thoracoscopy
Number of subjects: 42
Study: 7941212

Group type: EXPERIMENTAL
Intervention: Letter of information and reflection
Number of subjects: 76

Group type: COMPARATOR
Intervention: Letter of information without reflection
Number of subjects: 76

Group type: COMPARATOR
Intervention: No letter of information with reflection
Number of subjects: 76

Group type: COMPARATOR
Intervention: No letter of information without reflection
Number of subjects: 76
Study: 3257913

Group type: EXPERIMENTAL
Intervention: Intravenous administration of leucovorin calcium (25 mg)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Intramuscular administration of leucovorin calcium (25 mg)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Oral administration of leucovorin calcium (25 mg)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Intravenous and intramuscular administration
Number of subjects: 37

Group type: COMPARATOR
Intervention: All three treatments (Intravenous, Intramuscular, Oral)
Number of subjects: 37
Study: 31913154

Group type: EXPERIMENTAL
Intervention: Early weightbearing and ankle joint mobilization exercise
Number of subjects: 69

Group type: COMPARATOR
Intervention: Late weightbearing and ankle immobilization
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Late weightbearing and ankle mobilization
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Overall presence of heterotopic ossification
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Heterotopic ossification presence
Number of subjects: 69
Study: 29214896

Group type: EXPERIMENTAL
Intervention: CP900 series sound processor with Hybrid Hearing
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: CP900 with Hybrid Hearing
Number of subjects: 38

Group type: COMPARATOR
Intervention: Freedom Hybrid sound processor
Number of subjects: 38

Group type: COMPARATOR
Intervention: CP900 series sound processor (electric-only)
Number of subjects: 38
Study: 26724816

Group type: EXPERIMENTAL
Intervention: Disposable wash gloves
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional washing methods
Number of subjects: 0
Study: 23906415

Group type: EXPERIMENTAL
Intervention: Empagliflozin 10 mg
Number of subjects: 498

Group type: EXPERIMENTAL
Intervention: Empagliflozin 25 mg
Number of subjects: 498

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 498

Group type: EXPERIMENTAL
Intervention: Empagliflozin
Number of subjects: 498
Study: 23564914

Group type: EXPERIMENTAL
Intervention: Intraduodenal glutamine (7.5 or 15 g)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 20
Study: 19741062

Group type: EXPERIMENTAL
Intervention: rt‐PA 50 mg/2 h
Number of subjects: 118

Group type: COMPARATOR
Intervention: rt‐PA 100 mg/2 h
Number of subjects: 118
Study: 19049752

Group type: EXPERIMENTAL
Intervention: Cell saver group (n = 20)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (n = 20)
Number of subjects: 40
Study: 15897822

Group type: EXPERIMENTAL
Intervention: Combined manipulative treatment, stabilizing exercises, and physician consultation
Number of subjects: 204

Group type: COMPARATOR
Intervention: Physician consultation alone
Number of subjects: 204
Study: 12898859

Group type: EXPERIMENTAL
Intervention: Whole body bioimpedance technique
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Segmental measurement from the leg
Number of subjects: 0
Study: 10355243

Group type: EXPERIMENTAL
Intervention: To-be-combined figures that were partially occluded by irrelevant forms
Number of subjects: 0

Group type: COMPARATOR
Intervention: Previously visible regions of the figure presented after an occluder was removed
Number of subjects: 0
Study: 8522469

Group type: EXPERIMENTAL
Intervention: Fluconazole administered via feeding tube with concomitant enteral feeds
Number of subjects: 5

Group type: COMPARATOR
Intervention: Fluconazole administered as intravenous infusion over 1 h
Number of subjects: 5
Study: 2008781

Group type: EXPERIMENTAL
Intervention: Treatment group (received feedback on prescription errors)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (no feedback)
Number of subjects: 20
Study: 7042738

Group type: EXPERIMENTAL
Intervention: Bromocriptine
Number of subjects: 5

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5
Study: 30736711

Group type: EXPERIMENTAL
Intervention: Plyometric drop jump training (DJ20 and DJ40) for 7 weeks
Number of subjects: 39

Group type: COMPARATOR
Intervention: Control group (regular soccer training)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Plyometric drop jump training (DJ20 and DJ40)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Plyometric drop jump training (DJ40)
Number of subjects: 39
Study: 29278968

Group type: EXPERIMENTAL
Intervention: Paliperidone palmitate 1-month formulation (PP1M)
Number of subjects: 50
Study: 26903532

Group type: EXPERIMENTAL
Intervention: Candesartan cilexetil
Number of subjects: 130

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Metoprolol succinate
Number of subjects: 130
Study: 25003117

Group type: EXPERIMENTAL
Intervention: Human amniotic membrane (HAM) covered by PU foam
Number of subjects: 45

Group type: COMPARATOR
Intervention: Conventional polyurethane (PU) foam
Number of subjects: 45

Group type: COMPARATOR
Intervention: PU foil/paraffin gauze
Number of subjects: 45
Study: 22401676

Group type: EXPERIMENTAL
Intervention: Cemented Exeter femoral stem
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Cemented Exeter femoral stem with complete circumferential cement fracture
Number of subjects: 39
Study: 21048170

Group type: EXPERIMENTAL
Intervention: 1.5 g tranexamic acid in 100 mL normal saline solution
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: 3.0 g tranexamic acid in 100 mL normal saline solution
Number of subjects: 99

Group type: COMPARATOR
Intervention: Placebo (normal saline solution)
Number of subjects: 99
Study: 17403630

Group type: EXPERIMENTAL
Intervention: Preoperative RT-CT (radiotherapy 45 Gy on posterior pelvis + 5-fluorouracil 300 mg/m2/day for 5 days weekly during RT)
Number of subjects: 331

Group type: EXPERIMENTAL
Intervention: Preoperative RT-CT
Number of subjects: 331

Group type: COMPARATOR
Intervention: Postoperative RT-CT
Number of subjects: 331
Study: 16423743

Group type: EXPERIMENTAL
Intervention: 20 ms exposure duration
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 2000 ms exposure duration
Number of subjects: 0
Study: 14644719

Group type: EXPERIMENTAL
Intervention: Bimatoprost 0.03% once daily (n = 90)
Number of subjects: 177

Group type: COMPARATOR
Intervention: Combined timolol 0.5% and dorzolamide 2% twice daily (n = 87)
Number of subjects: 177
Study: 10942744

Group type: EXPERIMENTAL
Intervention: Bi‐AAT pacing (simultaneous right and left atrial triggered pacing at a rate of >/=85 bpm)
Number of subjects: 118

Group type: COMPARATOR
Intervention: RA‐AAI pacing (right atrial pacing at 45 bpm)
Number of subjects: 118

Group type: COMPARATOR
Intervention: RA‐AAT pacing (right atrial triggered pacing at a rate of >/=85 bpm)
Number of subjects: 118
Study: 8821686

Group type: EXPERIMENTAL
Intervention: Warm irrigant (37 degrees C from level-one fluid warmer)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Warm irrigant (35 degrees C from Ohio Servocare incubator)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Cold irrigant (17 degrees C)
Number of subjects: 28
Study: 1450626

Group type: EXPERIMENTAL
Intervention: High diastolic blood pressure group
Number of subjects: 78

Group type: COMPARATOR
Intervention: Low diastolic blood pressure group
Number of subjects: 78
Study: 6366664

Group type: EXPERIMENTAL
Intervention: Cefoperazone
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Cefoxitin
Number of subjects: 101

Group type: COMPARATOR
Intervention: Cefoperazone and Cefoxitin (both regimens)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Major postoperative infection
Number of subjects: 101
Study: 30265294

Group type: EXPERIMENTAL
Intervention: Personal Reminder Information and Social Management (PRISM) system
Number of subjects: 150
Study: 29506580

Group type: EXPERIMENTAL
Intervention: Starting antiplatelet drugs
Number of subjects: 720

Group type: COMPARATOR
Intervention: Avoiding antiplatelet drugs
Number of subjects: 720
Study: 27461440

Group type: EXPERIMENTAL
Intervention: Behavioural Activation (BA)
Number of subjects: 440

Group type: COMPARATOR
Intervention: Cognitive Behavioural Therapy (CBT)
Number of subjects: 440
Study: 24678807

Group type: EXPERIMENTAL
Intervention: Arotinolol combined with nifedipine (30 mg/d nifedipine + 20 mg/d arotinolol)
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Arotinolol combined with amlodipine (5 mg/d amlodipine + 20 mg/d arotinolol)
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Arotinolol combined with felodipine (5 mg/d felodipine + 20 mg/d arotinolol)
Number of subjects: 152
Study: 21798784

Group type: EXPERIMENTAL
Intervention: Pharmaceutical intervention with a pharmacist explaining prescribed drugs and providing a personalized medication timetable
Number of subjects: 100

Group type: COMPARATOR
Intervention: Routine clinical practice (Control group)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Pharmaceutical intervention with a pharmacist
Number of subjects: 100
Study: 21308266

Group type: EXPERIMENTAL
Intervention: Mind-body interventions (including yoga, relaxation, Tai Chi Chih, and music)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Cognitive behavioral therapy (CBT)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Mind-body interventions (general)
Number of subjects: 12
Study: 18506965

Group type: EXPERIMENTAL
Intervention: Modeling technique with mother as model (Group A)
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: Modeling technique with father as model (Group B)
Number of subjects: 155

Group type: COMPARATOR
Intervention: Tell show do approach (Group C)
Number of subjects: 155
Study: 16118067

Group type: EXPERIMENTAL
Intervention: Primary PCI
Number of subjects: 1351

Group type: COMPARATOR
Intervention: Thrombolysis
Number of subjects: 1351
Study: 12113387

Group type: EXPERIMENTAL
Intervention: Mask proportional assist ventilation (PAV)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Spontaneous breathing (SB)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Both groups (PAV and SB)
Number of subjects: 33
Study: 10081699

Group type: EXPERIMENTAL
Intervention: Luteinizing hormone-releasing hormone analogue (LH-RHa) started the first day of radiotherapy and administered every 4 weeks over 3 years
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Luteinizing hormone-releasing hormone analogue (LH-RHa) initiated in the last week of radiation therapy and continued until relapse
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Androgen suppression prior to and during radiation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adjuvant hormonal therapy with LH-RHa during and after radiation
Number of subjects: 0
Study: 8608360

Group type: EXPERIMENTAL
Intervention: Hormone Replacement Therapy (HRT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cyclical etidronate therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Salmon calcitonin
Number of subjects: 0

Group type: COMPARATOR
Intervention: HRT
Number of subjects: 0

Group type: COMPARATOR
Intervention: Salmon calcitonin therapy
Number of subjects: 0
Study: 2200187

Group type: EXPERIMENTAL
Intervention: Heparin 5000 IU + 0.5 mg DHE (HDHE) three times a day
Number of subjects: 404

Group type: COMPARATOR
Intervention: Acetyl‐salicylic‐acid (ASA) 0.5 g + dihydroergotamin (DHE) 2.5 mg three times a day
Number of subjects: 404
Study: 7082024

Group type: EXPERIMENTAL
Intervention: 5% crude coal tar in an absorbent ointment base (Aquaphor)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Absorbent ointment base alone
Number of subjects: 17
Study: 31208191

Group type: EXPERIMENTAL
Intervention: Cancer prevention education program (two 40-minute sessions)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Music video about cancer prevention (control group)
Number of subjects: 0
Study: 26880758

Group type: EXPERIMENTAL
Intervention: Wearing accelerometers
Number of subjects: 38

Group type: COMPARATOR
Intervention: Not wearing accelerometers
Number of subjects: 38